Supernus Pharmaceuticals Inc.

10/10/2024 | Press release | Distributed by Public on 10/10/2024 15:34

Supernus Pharmaceuticals to Host Webcast to Review Open Label Phase 2a Study of SPN 820 for the Treatment of Major Depressive Disorder